+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2020

  • ID: 5231069
  • Report
  • December 2020
  • Region: Global
  • 98 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Boston Scientific Corp
  • GTX Medical BV
  • Medtronic Plc
  • Neuronoff Inc
  • Nuvectra Corp
  • Soterix Medical Inc
  • MORE
Summary

The publisher's Medical Devices sector report, “Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Spinal Cord Stimulators (SCS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

SCS is a device that comprises a surgically-implanted electrical pacemaker and electrodes that connect to the spinal cord to treat chronic pain disorders.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Spinal Cord Stimulators (SCS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Spinal Cord Stimulators (SCS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Spinal Cord Stimulators (SCS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Boston Scientific Corp
  • GTX Medical BV
  • Medtronic Plc
  • Neuronoff Inc
  • Nuvectra Corp
  • Soterix Medical Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Spinal Cord Stimulators (SCS) Overview

3 Products under Development
3.1 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
3.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
3.3 Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
3.4 Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
3.5 Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials

4 Spinal Cord Stimulators (SCS) - Pipeline Products under Development by Companies
4.1 Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development
4.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development

5 Spinal Cord Stimulators (SCS) Companies and Product Overview
5.1 Boston Scientific Corp Company Overview
5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Cerevast Therapeutics Inc Company Overview
5.2.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Direct Spinal Therapeutics, Inc. Company Overview
5.3.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Duke University Company Overview
5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
5.5 GTX Medical BV Company Overview
5.5.1 GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview
5.6 Imperial College London Company Overview
5.6.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.7 Lawson Health Research Institute Company Overview
5.7.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview
5.8 Meagan Medical Inc. Company Overview
5.8.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medtronic Plc Company Overview
5.9.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Micro-Leads Inc Company Overview
5.10.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 MicroTransponder Inc Company Overview
5.11.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Neuronoff Inc Company Overview
5.12.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Nevro Corp Company Overview
5.13.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Nexstim Plc Company Overview
5.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Nuvectra Corp Company Overview
5.15.1 Nuvectra Corp Pipeline Products & Ongoing Clinical Trials Overview
5.16 Saluda Medical Pty Ltd Company Overview
5.16.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Soin Neuroscience Inc Company Overview
5.17.1 Soin Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Soterix Medical Inc Company Overview
5.18.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 SpineX Company Overview
5.19.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview
5.20 St. Jude Medical LLC Company Overview
5.20.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of California Los Angeles Company Overview
5.21.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of Minnesota Company Overview
5.22.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.23 Wavegate Technologies LLC Company Overview
5.23.1 Wavegate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.24 WISE s.r.l. Company Overview
5.24.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview

6 Spinal Cord Stimulators (SCS)- Recent Developments
6.1 Sep 03, 2020: Conduct a trial stimulation period before implanting a spinal cord stimulator (SCS) - letter to health care providers
6.2 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
6.3 Feb 28, 2020: Nevro and Stimwave reach worldwide settlement in patent infringement lawsuit: Stimwave agrees to a permanent injunction
6.4 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.5 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.6 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.7 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
6.8 Jan 27, 2020: Dr. Ioannis Skaribas, M.D., FASA, DABA performs the first Abbott Proclaim XR Spinal Cord Stimulator Procedure in Houston, TX
6.9 Jan 23, 2020: New Quality of Life and Functional Improvement data From Abbott's BOLD and TRIUMPH studies reinforce benefit of Proclaim XR Neurostimulation System in people living with chronic pain
6.10 Jan 22, 2020: Nevro top present new clinical evidence at the 23rd Annual North American Neuromodulation (NANS) Society Meeting
6.11 Jan 22, 2020: Nevro to present new clinical evidence at the 23rd Annual North American Neuromodulation (NANS) Society Meeting
6.12 Jan 22, 2020: Soin Neuroscience develops a new spinal cord stimulator to treat chronic pain
6.13 Jan 21, 2020: Saluda Medical highlights multiple presentations featuring Evoke ECAP-controlled, closed-loop SCS system at NANS annual meeting
6.14 Jan 21, 2020: DTM spinal cord stimulation using the Medtronic Intellis platform shows superior back pain relief compared to conventional SCS therapy in an RCT
6.15 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
6.16 Jan 14, 2020: Nevro announces preliminary unaudited fourth quarter and full year 2019 revenue
6.17 Dec 18, 2019: ­Nevro appoints Karen N. Prange to the company's board of directors
6.18 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.19 Dec 03, 2019: Micro-Leads announces $10m in funding for precision neuromodulation therapy

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Table 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Table 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
Table 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
Table 6: Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development
Table 7: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Next Generation SCS System - Product Status
Table 10: Next Generation SCS System - Product Description
Table 11: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Transdermal Electrical Neurostimulation Device - Product Status
Table 13: Transdermal Electrical Neurostimulation Device - Product Description
Table 14: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Iowa-Patch System - Product Status
Table 16: Iowa-Patch System - Product Description
Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Spinal Cord Stimulator - Product Status
Table 19: Spinal Cord Stimulator - Product Description
Table 20: GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Go-2 Targeted Epidural Spinal Stimulation Device - Product Status
Table 22: Go-2 Targeted Epidural Spinal Stimulation Device - Product Description
Table 23: Lift System - Product Status
Table 24: Lift System - Product Description
Table 25: GTX Medical BV - Ongoing Clinical Trials Overview
Table 26: Lift System - Activity Dependent Rehabilitation Via Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury
Table 27: Go-2 Targeted Epidural Spinal Stimulation Device - Efficacy of Spinal Epidural Electrical Stimulation (EES) in Combination with Robot-assisted Neurorehabilitation in Patients with Spinal Cord Injury (STIMO)
Table 28: Go-2 Targeted Epidural Spinal Stimulation Device - Targeting Improvements in Bowel Function and Quality of Life Using Epidural Stimulation and Training After Severe Spinal Cord Injury
Table 29: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Wireless Intraspinal Microstimulation System - Product Status
Table 31: Wireless Intraspinal Microstimulation System - Product Description
Table 32: Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Spinal Implant - Parkinson’s Disease - Product Status
Table 34: Spinal Implant - Parkinson’s Disease - Product Description
Table 35: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 36: DISCSS IFC System - Product Status
Table 37: DISCSS IFC System - Product Description
Table 38: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: MRI Surgical Lead - Product Status
Table 40: MRI Surgical Lead - Product Description
Table 41: Next Generation Intellis - Product Status
Table 42: Next Generation Intellis - Product Description
Table 43: PrimeADVANCED - Heart Failure - Product Status
Table 44: PrimeADVANCED - Heart Failure - Product Description
Table 45: Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: HD64 Implantable Therapy System - Product Status
Table 47: HD64 Implantable Therapy System - Product Description
Table 48: Intelligent Spinal Interface - Product Status
Table 49: Intelligent Spinal Interface - Product Description
Table 50: STIM-GRID MAP Spinal Cord Paddle - Product Status

List of Figures
Figure 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Figure 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Figure 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Figure 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
Figure 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Boston Scientific Corp
  • Cerevast Therapeutics Inc
  • Direct Spinal Therapeutics, Inc.
  • Duke University
  • GTX Medical BV
  • Imperial College London
  • Lawson Health Research Institute
  • Meagan Medical Inc.
  • Medtronic Plc
  • Micro-Leads Inc
  • MicroTransponder Inc
  • Neuronoff Inc
  • Nevro Corp
  • Nexstim Plc
  • Nuvectra Corp
  • Saluda Medical Pty Ltd
  • Soin Neuroscience Inc
  • Soterix Medical Inc
  • SpineX
  • St. Jude Medical LLC
  • University of California Los Angeles
  • University of Minnesota
  • Wavegate Technologies LLC
  • WISE s.r.l.
Note: Product cover images may vary from those shown
Adroll
adroll